Aileron Therapeutics announced that it received written notice on November 28, 2022 from The Nasdaq Stock Market noting that Aileron has regained compliance with the minimum bid price requirement under Listing Rule 5550(a)(2), which requires the company to maintain a minimum closing bid price of $1.00 per share, and the matter is now closed. Nasdaq staff made this determination after Aileron’s closing bid price was above $1.00 per share for 10 consecutive business days from November 11, 2022 to November 25, 2022.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ALRN:
- Aileron Therapeutics Regains Compliance with Nasdaq Listing Requirements
- Aileron Therapeutics announces 1-for-20 reverse stock split
- Aileron Therapeutics Announces a 1-for-20 Reverse Stock Split
- Aileron Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights
- Aileron Therapeutics Presents Results from Phase 1 Study in Healthy Volunteers Demonstrating ALRN-6924 Induced Cell Cycle Arrest in Bone Marrow Stem Cells and Hair Follicles at EORTC-NCI-AACR International Conference